North Bay Business Journal

Friday, February 14, 2014, 12:44 pm

Oculus third-quarter sales dip 5% as loss widens from Ruthigen spinoff

Print Friendly Print Friendly    

Share this item

    PETALUMA — Oculus Innovative Sciences, Inc. (Nasdaq: OCLS) on Thursday reported a 5.7 percent year-over-year dip in revenue for the company’s third fiscal quarter and increased expenses related to operations of its Ruthigen subsidiary.

    Oculus Innovative Sciences Oculus had revenue of $3.3 million for the three months ended Dec. 31, pointing to a decline in sales in the United States, Mexico and China, the Petaluma-based developer of wound, tissue and animal care products reported after the market closed.

    Oculus reported a narrower quarterly gross profit of $2.1 million, equivalent to 67 percent of product revenue, down from $2.5 million, or 73 percent, a year before.

    Operating expenses increased 16 percent to $3.2 million, attributed primarily to the company’s subsidiary Ruthigen, which is in the process of spinoff and planning for an initial public offering. Oculus had a $1 million operational loss for the quarter, up from $163,000 and attributed mostly to Ruthigen expenses.

    On Feb. 6, Oculus said it reached a deal with Ruthigen to finance up to $760,000 more in IPO costs, to be repaid at the time of the offering.

    Research-and-development costs increased by $266,000, to $775,000 in the third quarter from a year before.

    Quarterly net loss was $611,000, or 37 cents a share, down from $1.9 million, or 9 cents a share, the previous fiscal year. Oculus attributed that narrowing of year-to-date losses to a $1.6 million gain from the sale of Oculus shares by the company’s lender, which paid off $3 million in debt.

    Revenues for the past three quarters were $10.8 million, down 10.7 percent from $12.1 million a year before.

    Shares in Oculus were trading at over $3 near the close of the session Friday, down more than 4 percent from Thursday’s closing price.

    Copyright © 1988–2015 North Bay Business Journal
    View the policy for linking to website content.

    Print Friendly Print Friendly    

    Submit Your Comments


    Required, will not be published

    Comments are moderated and generally will be posted if they are on-topic and not abusive. For more information, please see our Comments and Letters Policy. To share this item by email or social media, use the links above.

    Do not use this form to contact people, companies or organizations mentioned in this story. Contact them directly. Private messages left here will be deleted.